Cordectomy by CO2 laser or radiotherapy for small T1a glottic carcinomas: Costs, local control, survival, quality of life, and voice quality

Head and Neck

Volumn 29, Issue 2, 2007, Pages 128-136

  Goor, Kim M ^a   Peeters, A Jeanne G E ^b   Mahieu, Hans F ^b   Langendijk, Johannes A ^b,c   Leemans, C René ^b   Verdonck De Leeuw, Irma M ^b   Van Agthoven, Michel ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Costs and cost analysis; Glottis; Head and neck neoplasms; Laryngeal cancer; Laryngeal disease; Laryngeal neoplasms; Laser surgery; Quality of life; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARBON DIOXIDE LASER; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LARYNX CARCINOMA; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VOICE; CARCINOMA; COST; ECONOMICS; GLOTTIS; LARYNGOSCOPY; LARYNX TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; RADIOTHERAPY; TUMOR RECURRENCE; VOCAL CORD;

CARBON DIOXIDE;

ADULT; AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CARCINOMA; COSTS AND COST ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LARYNGOSCOPY; LASER SURGERY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY; RETROSPECTIVE STUDIES; VOCAL CORDS; VOICE QUALITY;

EID: 33846478703     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20500     Document Type: Article

References (31)

1. Ferlay J, Bray F, Sankila R, Parkin DM. EUCAN: Cancer Incidence, Mortality and Prevalence in the European Union 1998. Lyon, France: IARC; 1999.
2. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99-166.
3. Hordijk GJ, Kaanders JH. [CBO guideline 'larynx carcinoma']. Ned Tijdschr Geneeskd 2001;145:998-1002.
4. Chatani M, Matayoshi Y, Masaki N. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma. Strahlenther Onkol 1993;169:102-106.
5. Cragle SP, Brandenburg JH. Laser cordectomy or radiotherapy: cure rates, communication, and cost. Otolaryngol Head Neck Surg 1993;108:648-654.
6. Delsupehe KG, Zink I, Lejaegere M, Bastian RW. Voice quality after narrow-margin laser cordectomy compared with laryngeal irradiation. Otolaryngol Head Neck Surg 1999;121:528-533.
7. Mahieu HF, Patel P, Annyas AA, van der Laan T. Carbon dioxide laser vaporization in early glottic carcinoma. Arch Otolaryngol Head Neck Surg 1994;120:383-387.
8. 2-laser vaporization of early glottic carcinoma, oncological and functional results, in: First International Workshop on Laser Surgery in ENT, State of the Art. Antwerp, Belgium; Sept 1999.
9. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx. Am J Otolaryngol 1994;15:250-257.
10. 2 laser endoscopic resection. Tumori 2000;86:277-282.
11. Smee R, Bridger GP, Williams J, Fisher R. Early glottic carcinoma: results of treatment by radiotherapy. Australas Radiol 2000;44:53-59.
12. Specter JG, Sessions DG, Chao KS, et al. Stage I (T1 NO MO) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck 1999;21:707-717.
13. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol 1993;14:116-121.
14. Zeitels SM. Phonomicrosurgical treatment of early glottic cancer and carcinoma in situ. Am J Surg 1996;172:704-709.
15. Peeters AJ, Van Gogh CD, Goor KM, Verdonck-de Leeuw IM, Langendijk JA, Mahieu HF. Health status and voice outcome after treatment for T1a glottic carcinoma. Eur Arch Otorhinolaryngol 2004;261:534-540.
16. Remacle M, Eckel HE, Antonelli A, et al. Endoscopic cordectomy. A proposal for a classification by the Working Committee, European Laryngological Society. Eur Arch Otorhinolaryngol 2000;257:227-231.
17. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 1997.
18. Oostenbrink JB, Koopmanschap MA, Rutten FFH. Handleiding voor kostenonderzoek methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen; 2000.
19. Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson B, Benninger MS. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997;6:66-70.
20. Verdonck-de Leeuw IM, Boon-Kamma B, Van Gogh CD, Greven AJ, Peeters AJGE, Mahieu HF. Een multidimensioneel stemonderzoeksprotocol: het meten van stemkarakteristieken van patiënten met een klein larynxcarcinoom. Logop Foniatr 2002;12:340-345.
21. Kinnersley P, Peters T, Stott N. Measuring functional health status in primary care using the COOP-WONCA charts: acceptability, range of scores, construct validity, reliability and sensitivity to change. Br J Gen Pract 1994;44:545-549.
22. 2-laserbehandeling voor de behandeling van het glottisch larynxcarcinoom. Rotterdam: Erasmus Universiteit; 2002.
23. Loughran S, Calder N, Macgregor FB, Carding P, MacKenzie K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005;30:42-47.
24. Smith JC, Johnson JT, Cognetti DM, et al. Quality of life, functional outcome, and costs of early glottic cancer. Laryngoscope 2003;113:68-76.
25. Stoeckli SJ, Schnieper I, Huguenin P, Schmid S. Early glottic carcinoma: treatment according patient's preference? Head and Neck 2003;25:1051-1056.
26. Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann Otol Rhinol Laryngol 2001;110:312-318.
27. Myers EN, Wagner RL, Johnson JT. Microlaryngoscopic surgery for T1 glottic lesions: a cost-effective option. Ann Otol Rhinol Laryngol 1994;103:28-30.
28. Foote RL, Buskirk SJ, Grado GL, Bonner JA. Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck 1997;19:692-700.
29. Gregoire V, Hamoir M, Rosier JF, et al. Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiother Oncol 1999;53:1-13.
30. Schulman K, Burke J, Drummond M, et al. Resource costing for multinational neurologic clinical trials: methods and results. Health Econ 1998;7:629-638.
31. van Agthoven M, van Ineveld BM, de Boer MF, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer 2001;37:2204-2211.